Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica with very late onset.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Reward responsiveness and fatigue in multiple sclerosis.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Biomarkers in multiple sclerosis.
Psychiatric disorders in neurology.
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »